Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin

Chemoresistance to cisplatin is a principal cause of treatment failure and mortality of advanced bladder cancer (BC). The underlying mechanisms remain unclear, which hinders the development of preventive strategies. Recent data indicate that pyruvate kinase M2 (PKM2), a glycolytic enzyme for Warburg...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xing, Zhang, Fenglin, Wu, Xue-Ru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380992/
https://www.ncbi.nlm.nih.gov/pubmed/28378811
http://dx.doi.org/10.1038/srep45983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380992/
https://www.ncbi.nlm.nih.gov/pubmed/28378811
http://dx.doi.org/10.1038/srep45983

Ejemplares similares